Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

36.56
BATS BZX Real-Time Price
As of 12:37pm ET
 +0.65 / +1.80%
Today’s Change
34.57
Today|||52-Week Range
66.55
-44.31%
Year-to-Date
Don't Give Up on Battered Teva Stock; a Turnaround Is Coming
9:42am / TheStreet.com - Paid Partner Content
Teva Pharmaceutical Is Down to Key Support. Did I Say Key?
Dec 06 / TheStreet.com - Paid Partner Content
Stop Listening to 'The Market'
Dec 08 / TheStreet.com - Paid Partner Content
Questions Mount at Teva Amid C-suite Change
Dec 06 / TheStreet.com - Paid Partner Content
Teva Copaxone EU Label to Omit Pregnancy Contraindication
Dec 07 / Zacks.com - Paid Partner Content
2 Stocks That Could Soar Under a Donald Trump Presidency
Dec 05 / MotleyFool.com - Paid Partner Content
Stock Market Roundup Dec. 6: CMG, TEVA, Oil Futures Fall
Dec 06 / Zacks.com - Paid Partner Content
The Sole Reason Teva Pharmaceutical Industries Ltd. Sank 12% in November
Dec 02 / MotleyFool.com - Paid Partner Content
Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today
Dec 06 / Zacks.com - Paid Partner Content
What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?
Nov 29 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close35.91
Today’s open36.28
Day’s range36.28 - 36.85
Volume186,227
Average volume (3 months)8,691,310
Market cap$36.4B
Dividend yield3.72%
Data as of 12:37pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-5.11%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-3.22%
P/E ratio21.2
Price/Sales2.89
Price/Book1.23

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.10+0.37%
OASMOasmia Pharmaceutica...0.000.00%
Data as of 12:21pm ET, 12/09/2016

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$1.37
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts


Search for Jobs